metharbital

metharbital is a long-acting barbiturate used primarily to treat severe anxiety disorders.

the physician prescribed metharbital to manage the patient's chronic insomnia.

metharbital dosage must be carefully calculated based on the patient's weight and medical history.

long-term metharbital use can lead to physical dependence and tolerance.

the study examined the pharmacological effects of metharbital on the central nervous system.

metharbital should be avoided in patients with a history of substance abuse.

combining metharbital with alcohol significantly increases the risk of respiratory depression.

the hospital's pharmacy maintains strict inventory controls for metharbital supplies.

metharbital metabolism varies considerably across different patient populations.

clinical guidelines recommend gradual metharbital dosage reduction to manage withdrawal symptoms.

patients must be closely monitored during metharbital therapy to prevent potential adverse effects.

the pharmaceutical company conducted clinical trials to evaluate metharbital efficacy and safety.